Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Glofitamab Treatment in Relapsed or Refractory DLBCL after CAR T-Cell Therapy.

Autor: Rentsch V; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Seipel K; Department of Biomedical Research, University of Bern, 3008 Bern, Switzerland., Banz Y; Institute of Pathology, Inselspital, University of Bern, 3008 Bern, Switzerland., Wiedemann G; Center of Laboratory Medicine (ZLM), Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Porret N; Center of Laboratory Medicine (ZLM), Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Bacher U; Department of Hematology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2022 May 20; Vol. 14 (10). Date of Electronic Publication: 2022 May 20.